Skip to content

Correlation analysis of clinical and imaging evaluation indexes in patients with cardiovascular and cerebrovascular events

Correlation analysis of clinical and imaging evaluation indexes in patients with cardiovascular and cerebrovascular events

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069194
Enrollment
Unknown
Registered
2023-03-09
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardio cerebrovascular disease

Interventions

Patients with cardio-cerebrovascular events:N/A

Sponsors

the First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Cardiovascular event: the patient has at least one of the following clinical symptoms: myocardial infarction, arrhythmia, coronary heart disease, angina pectoris, myocardial ischemia, heart failure; (2) Cerebrovascular accident: the patient has at least one of the following clinical symptoms: stroke (acute cerebral infarction, acute cerebral hemorrhage), vertigo/dizziness, lacunar cerebral infarction, TIA, posterior circulation ischemia, etc.

Exclusion criteria

Exclusion criteria: (1) The diagnosis is not clear and the clinical or imaging data are not complete. (2) It does not meet the above inclusion criteria for cardiovascular and cerebrovascular events. (3) Medical record data is missing.

Design outcomes

Primary

MeasureTime frame
Iodine contrast enhancement;Epicardial fat quantification;Risk factors of cardiovascular and cerebrovascular events;

Secondary

MeasureTime frame
Image evaluation indicators;

Countries

China

Contacts

Public ContactFang Tang

The First Affiliated Hospital of Chengdu Medical College

tangfang301172@163.com+86 13981713020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026